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Efficiency of membrane technology, activated charcoal,
and a micelle-clay complex for removal of the acidic
pharmaceutical mefenamic acid
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The efficiency of sequential advancedmembrane technology wastewater treatment plant towards removal of a widely used non-steroid
anti-inflammatory drug (NSAID) mefenamic acid was investigated. The sequential system included activated sludge, ultrafiltration
by hollow fibre membranes with 100 kDa cutoff, and spiral wound membranes with 20 kDa cutoff, activated carbon and a reverse
osmosis (RO) unit. The performance of the integrated plant showed complete removal of mefenamic acid from spiked wastewater
samples. The activated carbon column was the most effective component in removing mefenamic acid with a removal efficiency of
97.2%. Stability study of mefenamic acid in pure water and Al-Quds activated sludge revealed that the anti-inflammatory drug was
resistant to degradation in both environments. Batch adsorption of mefenamic acid by activated charcoal and a composite micelle
(otadecyltrimethylammonium (ODTMA)–clay (montmorillonite) was determined at 25.0◦C. Langmuir isotherm was found to fit the
data with Qmax of 90.9 mg g−1 and 100.0 mg g−1 for activated carbon and micelle-clay complex, respectively. Filtration experiment
by micelle-clay columns mixed with sand in the mg L−1 range revealed complete removal of the drug with much larger capacity than
activated carbon column. The combined results demonstrated that an integration of a micelle-clay column in the plant system has a
good potential to improve the removal efficiency of the plant towards NSAID drugs such as mefenamic acid.
Keywords: Anti-inflammatory drugs, wastewater, membrane technology, activated carbon, micelle-clay complex, adsorption
isotherms, mefenamic acid.
Introduction
The consumption of water throughout the world is increas-
ing, and the demand on water resources for household,
commercial, industrial, and agricultural purposes is rising.
This soaring demand is due to a rapidly expanding popula-
tion, industrial expansion, and the need to expand irrigated
agriculture. It is worth noting that there is a decrease in
fresh water resources and low water availability.[1] Thus the
treatment and reuse of wastewater for agriculture irrigation
becomes a necessity to overcome this shortage.[2]
The occurrence of drugs in the environment is a subject
of concern. The contamination is due to the consumption
Address correspondence to Rafik Karaman, Department of
Bioorganic Chemistry, Faculty of Pharmacy, Al-QudsUniversity,
Jerusalem 20002, Palestine; E-mail: dr karaman@yahoo.com
Received February 19, 2013.
and the excretion of large quantities of pharmaceuticals via
urine and feces in wastewaters. In fact, many administered
pharmaceuticals are excreted without any chemical change
or are released in conjugated or more polar transformed
forms. The unused portion of pharmaceuticals can be also
a source of sewage contaminations. In fact, a survey con-
ducted by Kuspis and Krenzelok in the United States[3]
indicated that more than 35% of people flushed medica-
tions down the toilet or sink. However, the percentage of
unused medicines sold is still unknown.[4]
Even though residues of pharmaceuticals and their
metabolites are usually detectable in the environment at
trace levels, the low concentration level (ng/L-µg/L) can
induce toxic effects, as in the cases of antibiotics and
steroids that cause resistance in natural bacterial popula-
tions, or endocrine disruption effects.[5] Another main con-
cern is the chronic and/or synergistic effects of “cocktails”
of pharmaceuticals that humans release to water, which
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may enter into drinking water and be consumed by the
population.[6–8]
Pharmaceuticals, especially medicines are designed to
interact with receptors in human and animal bodies, but
in aquatic environment the organisms having the same or
similar enzymes or receptors as humans could experience
similar pharmacodynamic effects, resulting in the destruc-
tion of organisms that are vital to environment.[6]
There are several methods for removal of pharmaceuti-
cals from wastewater, among them:
(a) biodegradation process by which biological degrada-
tion can take place in wastewater by means of aerobic/
anaerobic microbial degradation of the drug substance
leading to reduction of the parental pharmaceuticals
and/or their metabolites during wastewater treatment.
The microbes include bacteria, yeasts, fungi, protozoa,
and unicellular plants and rotifers; some of these or-
ganisms have the ability to degrade some of most haz-
ardous and recalcitrant chemicals;
(b) deconjugation process by which pharmaceuticals are
often metabolized in the liver, consequently sulfate
and gluconoride conjugates of the parental drug
are excreted. These excreted compounds will further
deconjugate in domestic wastewater and within sewage
treatment plants for organic compounds such as steroid
hormones. These compounds were detected and at-
tributed to the presence of large amounts of β-
glucoronidase enzyme.
Gluconorides and sulfates of drugs will be degraded
by the same process. This effect increases the excreted
contribution of the active drugs to sewage and effluents;
(c) partitioning between the aqueous and organic biomass
phase is considered the key component in determining
the ultimate concentration of organic pollutants. Com-
pounds with high log P (lipophylic molecules) values
are known to sorb to sludge, whereas substances with
lower values are more likely to remain in the aquatic
phase, depending on the individual compound, and
other substances sorbing to solids;
(d) removal during sludge treatment by which drugs may
also be degraded by a biotic process (hydrolysis) during
sewage treatment process. Many pharmaceuticals are
not thermally stable, and so they might be expected to
break down during chemical and biological processes
at higher temperatures; and
(e) photodegradation by which several pharmaceuticals
might be degraded due to the action of sunlight.
Some pharmaceuticals such as diclofenac, which is
analgesic/anti-inflammatory drug have been shown to
degrade in aquatic environment due to ultraviolet (UV)
light.[9–12]
Due to an incomplete elimination in wastewater treat-
ment plants using the conventional treatment method,
residues of pharmaceuticals are found in both wastewater
and surface water.[13] To improve this situation an applica-
tion of advanced treatment techniques, such as membrane
Scheme 1. Chemical structures for Mefenamic acid (1), and
ODTMA (2).
filtration technology is required. A significant number of
studies reported a satisfactory efficiency of nanofiltration,
reverse osmosis,[14] advanced oxidation processes,[15] and
activated carbon adsorption in removing pharmaceuticals
from wastewater.[14,16].
Mefenamic acid [(2,3-dimethyl diphenyl) amino-2-
carboxylic acid] (structure 1 in Scheme 1) belongs to
the acidic, nonsteroidal, and anti-inflammatory drugs
(NSAIDs). It is used for the relief of short-term moder-
ate pain lasting less than 1 week, such as muscular aches
and pains, menstrual cramps, headaches, and dental pain.
It is typically prescribed for oral administration.[17,18]
Anti-inflammatory drugs such as ibuprofen, naproxen,
mefenamic acid and ketoprofen were frequently detected
in the discharges of wastewater treatment plants (WWTPs)
and river water in Japan. The average concentrations range
for those NSAIDs, ibuprofen, naproxen, mefenamic acid
and ketoprofen, was 60–1580 ng/L in the effluent.[19] High
removal efficiencies of the drugs were observed in the
WWTP that has longer hydraulic retention time.[19]
In Sweden, removal of five NSAIDs, ibuprofen, ketopro-
fen, naproxen, diclofenac andmefenamic acid was assessed
by batch experiments, with suspended biofilm carriers
and activated sludge from several full-scale wastewater
treatment plants. Biofilm carriers from full-scale nitrifying
wastewater treatment plants, demonstrated considerably
higher removal rates per unit biomass (i.e., suspended
solids for the sludge and attached solids for the carriers)
of diclofenac, ketoprofen and mefenamic acid compared
to the sludge.[20]
The goal of this study was to explore the efficiency of ad-
vanced treatment technologies which consist of integration
of activated sludge process with ultra-filtrationmembranes,
hollow fiber and spiral wound membranes, activated car-
bon adsorbent, micelle-clay filters, and reverse osmosis in
removing mefenamic acid.
The integrated components assembled in the wastewater
treatment plant atAl-QudsUniversity alongwith amicelle-
clay complex octadecyltrimethylammonium (ODTMA,
structure 2 in Scheme 1) and activated charcoal were tested
for the removal of mefenamic acid from wastewater.
The micelle-clay composite used in this study was pos-
itively charged, had large surface area and included large
hydrophobic domains. It was shown by X-ray diffraction,
electron microscopy and adsorption experiments that the
material characteristics of the micelle-clay complex are
D
ow
nl
oa
de
d 
by
 [R
afi
k K
ara
ma
n]
 at
 08
:38
 15
 A
ug
us
t 2
01
3 
Charcoal and micelle-clay complex for mefenamic acid removal 1657
Fig. 1. Flow diagram of the waste-water treatment plant (WWTP) at Al-Quds University (color figure available online).
different from those of an organo-clay complex, which is
formed by adsorption of the same organic cation ODTMA
(Octadecyltrimethylammonium) as monomers.[21] Micelle-
clay composites have already been proven useful in the re-
moval of about 20 neutral and anionic pollutants.[22–24]
Experimental
Instrumentation
HPLC analyses were performed with High Performance
Liquid Chromatography (HPLC-PDA) system, which con-
sists of an alliance 2695 HPLC (Waters, Milford, MA,
USA), and a Waters Micromass R© MasslynxTM detector
with Photo-diode array (Waters 2996). Data acquisition
and control were carried out using EmpowerTM software
(Waters). Analytes were separated on a 4.6 mm × 150 mm
C18XBridge R© column (5µmparticle size) used in conjunc-
tionwith a 4.6mm× 20µmXBridgeTM C18 guard column.
To construct the calibration curve for mefenamic acid, sev-
eral concentrations of the drug (0.8, 2.0, 4.0, 10.0, 20.0, 80,
100, 200 and 400.0 ppm) were prepared. Then, 20 µL of
each solution was injected into the HPLC and the peak for
mefenamic acid was recorded using the following HPLC
conditions: C18 column, wavelength= 350 nm, flow rate=
1.0mL/min. Peak area vs. concentration ofmefenamic acid
(mg/L) was then plotted, and R2 of the plot was recorded.
Microfilter was used with 0.45 µm (Acrodisc R© GHP, Wa-
ters); pH meter model HM-30G: TOA electronicsTM was
used in this study to measure the pH value for the sam-
ples. The C18 (1 g) cartridges (6cc single use) for general
laboratory use were purchased from the Waters company.
The wastewater treatment plant (WWTP) at Al-Quds
University consists of a primary treatment (two-stage pri-
mary settling basin), secondary (activated sludge with a
hydraulic retention time of 16–20 h, coagulation and chlo-
rination) treatment (Fig. 1). Then the secondary effluent is
introduced to a sand filter before entering the ultrafiltration
(UF) membrane (hollow fiber and spiral wound). After the
ultrafiltration process, the effluent is subjected to activated
carbon absorbers followed by a reverse osmosis (advanced
treatment). Then a blend of all effluents is used for irriga-
tion. The ultrafiltration process is made of two small scale
membrane treatment plants with a capacity of 12 m3/day.
The first UF unit is equipped with two pressure vessels
(AST Technologies, model number 8000 WW 1000−2M)
that house the hollow fiber membranes with 100 kD cutoff
(AST Technologies, Model No. 8000- WWOUT-IN-8080,
Sigma-Aldrich, Munich, Germany). The two units are de-
signed to deliver 1.5 m3/h. The second unit is equipped
with 2× 4 inch pressure vessels with pressure resistance up
to 150 psi.
Each vessel holds two separation membranes (spiral
wound with 20 kD cutoffs, which are equivalent to 0.01
micron separation rate). The designed permeate capacity
of the system is 0.5–0.8 m3/h. This membrane can remove
bacteria, suspended solids, turbidity agents, oil and emul-
sions. The reverse osmosis (RO) system consists of 1 × 4
inch pressure vessel made from composite material with
pressure resistance up to 400 psi. The vessel holds two
4-inch special thin film separation membranes made of
polyamide with pH range 1–11 (BW30-4040 by Dow Film
Tec., Edina, MN, USA). Membrane anti-scalants made of
phosphate in water with active ingredient of o-phosphonic
acid disodium salt (Product NCS-106-FG, Dow Film Tec.)
are continuously dosed to the RO feed at concentration of
4 ppm in order to prevent deposition of divalent ions. The
system is designed to remove major ions and heavy met-
als. The designed RO permeate capacity of the system is
0.45–0.5 m3/h.
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Chemicals and reagents
Pure standard of mefenamic acid (>99%) was obtained
from Beir-Zeit pharmaceutical company (Ramallah,
Palestine). Acetonitrile and methanol HPLC grade,
o-phosphoric acid, magnesium sulfate, charcoal activated
granules with particle size (≤700.0 µ), and octadecyl-
trimethyl ammonium (ODTMA) complex were purchased
from Sigma Chemical Company (Munich, Germany).
Methods
Preparation of micelle-clay complex
TheODMTAmicelle-clay complexwas prepared bymixing
a clay-mineral (montmorillonite) with cationic surfactant
octadecyltrimethylammonium (for the chemical structure
of ODTMA, see Scheme 1) with a critical micelle concen-
tration (CMC) value of 0.3 mM as described previously.[22]
Briefly, 12 mM of ODTMA was stirred with 10 g L−1
clay for 72 h. Suspensions were centrifuged for 20 min at
15,000 g, supernatants were discarded, and the complex
was lyophilized. The obtained complex by virtue of its pos-
itive chargewith hydrophobic region is capable of efficiently
binding negatively charged organic molecules.[21–26]
Efficiency of micelle (ODTMA)-clay complex
and charcoal for removal of mefenamic acid
Here theODTMA-clay complexwas tested for a removal of
mefenamic acid from water using the following procedure:
200 mg L−1 of mefenamic acid was prepared in buffer at
pH= 8.0. The pHwas adjusted by sodium hydroxide (1M);
100 mL from this solution were transferred to a 200-mL
Erlenmeyer flask (Darmstadt, Germany), 0.5 g of charcoal,
or micelle (ODTMA)-clay complex was then added to the
flask. Then the flask was shaken for 180 min. Samples were
taken at different time intervals: 0, 5, 10, 20, 30, 40, 50,
60, 80, 100, 120, 150 and 180 min. Then, each sample was
centrifuged for 5 min at 250 rpm, passed through 0.45-µM
filter and analyzed by HPLC.
Adsorption isotherms
Equilibrium relationships between adsorbents (micelle-clay
complex andactivated charcoal) and adsorbate (mefenamic
acid) was accomplished by studying the percentage ad-
sorbate removal whose concentrations ranged from 50 to
1000 mg L−1 in a volume of 100 mL. The pH of the initial
solutions was adjusted to 8.0. The sorbent dose was 0.5 g
of either charcoal or ODTMA-clay complex.
Analysis of adsorption isotherms
Adsorption isotherms were analyzed by the linear form of
the Langmuir isotherm, Eq. 1, as in:[26]
Ce/Qe = 1/(kQmax)+ Ce/Qmax (1)
in which Ce (mg/L) is equilibrium concentration of mefe-
namic acid, Qe (mg/g) is equilibrium mass of adsorbed
mefenamic acid per gramof complex or charcoal, k (L/mg)
is Langmuir binding constant, and Qmax (mg/g) is maxi-
mum mass of drug removed per gram of complex, or char-
coal.
Column experiments. Column filter experiments were per-
formed with 100/1 (w/w) mixtures of quartz sand and
ODTMA-clay complex (20 cm layer) in a column of 25 cm
length and 5 cm diameter, which included either 6.5 g of
micelle-clay complex, or activated carbon. The bottom of
the column was covered by 3 cm layer of quartz sand.
Quartz sand was thoroughly washed by distilled water and
dried at 105◦C for 24 h. A solution of mefenamic acid at a
concentration of 9.42 ppm was passed through the above
columns. The flow rate was 52 mL min−1. Fractions were
collected for assay of mefenamic acid.
Stability study of mefenamic acid
Stability study in distilled water. Stability study of mefe-
namic acid was performed with a 50 mg L−1 solution,
prepared by dissolving mefenamic acid in distilled water
adjusted to pH 8.0 using 1M sodium hydroxide. Samples
at specific time intervals: 0, 1, 2, 4, 5, 10, 15, 20, 25 and
30 days were taken, and analyzed by HPLC.
Stability study in the presence of Al-Quds sludge. Stabil-
ity study for mefenamic acid in the presence of Al-Quds
sludge was performed by adding 1000 mL of suspended
sludge (25% concentration) to 0.5 g of sorbent under con-
tinuous aeration to maintain bacterial growth in the sludge
environment. Reproducibility studies were performed in
triplicate and the average values were recorded together
with standard deviations.
Physical, chemical and biological parameters
of Al-Quds sludge
The physical, chemical and biological qualities of Al-Quds
University sludge used in the stability studies are presented
in Table 1. Careful inspection of Table 1 reveals that the
sludge is rich in N and P with high values of BOD, COD,
TDS, settable solids and bacterial count. These values are
expected since the analyzed samples were taken from the
aeration tank in the activated sludgeunitwithin thewastew-
ater treatment plant.
Data obtained by physiological and biochemical char-
acterization of bacterial community in Al-Quds activated
sludge allowed the identification of the following bacterial
species: Escherichia coli, Enterobacter sakazakii, Citrobac-
ter freundii, Pseudomonas aeruginosa,Klebsiella pneumonia,
Enterobacter cloacae, Enterobacter amnigenus, Enterobac-
ter aerogenes, Salmonella spp., and Serratia liquefaciens.
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Table 1. Physical, chemical and biological parameters for wastewater sample (Al-Quds University WWTPs).
Parameter Results Units Parameter Results Units
pH 7.32 — TSS 3700 ± 100 mg/L
Conductivity 2000 µSm/cm BOD 900 ± 150 mg/L
Temperature 15.5 ◦C COD 1900 ± 300 mg/L
Turbidity 5000 ± 200 NTU NH4-N 59.5 mg/L
DO 0.4 mg/L PO4-P 14.3 mg/L
TS 4200 ± 200 mg/L FC (E.coli) 290,000 ± 150,000 cfu/100 mL
TDS 620 ± 50 mg/L TC 6,500,000 ± 3,000,000 cfu/100 mL
Settable solids 240 mL/L TAC 2,600,000 ± 1,300,000 cfu/100 mL
DO: Dissolved Oxygen, TAC: Total Aerobic Count.
Efficiency of the wastewater treatment plant (WWTP)
of Al-Quds University for removal of mefenamic acid
The efficiency of different units of the advanced integrated
wastewater treatment plant of Al-Quds University for the
removal of mefenamic acid from wastewater was studied
by spiking the secondary effluent with 40 mg L−1 of drug
in a storage tank (25 g mefenamic acid in 625 L secondary
treated wastewater). Samples were taken from the follow-
ing points of the WWTP: (1) storage tank (before running
wastewater treatment plant) (2), (3), and (4) feed-, brine-
and product-points of the HF-UF membrane, respectively
(5) and (6) concentrate-, and permeate-UF point of the
HF-SW membrane, (7) activated carbon point, and (8) re-
verse osmosis point (Fig. 1). These samples were treated as
follows: 10 mL of sample was loaded into a C18 cartridge,
and allowed to pass through a cartridge by effect of gravity.
Mefenamic acid adsorbed on the C18 cartridge was then
eluted using 10mL of acetonitrile; 20µL of the eluted solu-
tion was injected into the HPLC and chromatograms were
taken.
Fig. 2. Adsorption isotherms for the removal of mefenamic acid
by micelle-clay complex [] and by activated charcoal () (pH
8.0, Temp. 25◦C).
Results and discussions
Stability study of mefenamic acid
The results showed that mefenamic acid was stable in both
distilled water and Al-Quds University activated sludge
during a period of more than one month.
Adsorption isotherms
The adsorption of mefenamic acid at several initial concen-
trations (50, 100, 200, 500, and 1000 mg/L) on a micelle-
clay complex and activated charcoal was investigated
(Fig. 2). The data fitted the Langmuir isotherm (Eq. 1)
with R2 greater than 0.99 for both cases (Fig. 3). The Lang-
muir constants (k and Qmax) were calculated and their val-
ues are presented in Table 2. Inspection of Table 2 revealed
that the micelle-clay complex has larger k and Qmax values
than activated carbon, thus rendering the former as a better
adsorbent for the removal of mefenamic acid.
Kinetics of adsorption of mefenamic acid on the
micelle-clay complex and activated charcoal
Mefenamic acid removal by a micelle-clay complex and ac-
tivated charcoal was studied at pH 8.0. Samples were taken
at different time intervals (0–180 min). The results revealed
that for a micelle-clay complex only 5 min sufficed for com-
plete removal of mefenamic acid (97% removal), whereas
for activated charcoal only 28% was removed during the
Table 2. Langmuir adsorption parameters (k and Qmax) and the
correlation coefficient (R2) values obtained from the adsorption
of mefenamic acid on both adsorbents, a micelle-clay complex
and activated charcoal.
Langmuir
Adsorbents K (L mg) Qmax (mg g) R2
Micelle-clay complex 0.105± 0.02 100.0± 5 0.990
Charcoal 0.065± 0.01 90.9± 3 0.999
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Table 3. Removal of Mefenamic acid by filtration of its solution
(9.42 mgL−1) through a laboratory filter, which included either a
micelle-clay complex, or activated carbon mixed with excess sand
at 1:100 (w/w).a
Emerging
concentration
Volume (mg L)
filtered Type % Removed
(L) column Column 1 Column 2 exp. (avg)
0.78 Micelle clay complex 0 0 100± 0
Activated carbon 3.10 3.90 63± 5
1.56 Micelle clay complex 0 0 100± 0
Activated carbon 4.21 4.91 51.6± 5
2.34 Micelle clay complex 0 0 100± 0
same period. These results indicate that the adsorption of
mefenamic acid on a micelle-clay complex is much faster
than that on activated charcoal. This difference between the
two adsorbents can be attributed to electrostatic interac-
tions between the micelle-clay complex and the hydrophilic
moiety of mefenamic acid, which are absent in activated
carbon. However, the result that the activated carbon is
characterized by slow kinetics of adsorption is also ob-
served in the case of neutral pollutants, e.g., bromacil.[27]
The relatively slow kinetics of adsorption is more striking
in filtration, as demonstrated next.
Filtration results
Mefenemic acid solutions in the mg L−1 range were passed
through filters which included the micelle-clay complex or
activated carbon mixed with excess sand at 1:100 ratios
(w/w). The results are presented in Table 3. The results
indicate a significant advantage of the micelle-clay filter
in removing mefenamic acid compared to that removed by
activated charcoal. Thiswas not surprising, since the results
for the adsorption isotherm and in particular the kinetics
Fig. 3. Langmuir isotherms for the removal of mefenamic acid by
micelle-clay complex () and by activated charcoal [] (pH 8.0,
Temp. 25◦C).
have clearly shown that the micelle-clay-complex was more
efficient than activated carbon in removingmefenamic acid
from water.
Efficiency of the wastewater treatment plant (WWTP)
at Al-Quds University for mefenamic acid removal
The efficiency of WWTP at Al-Quds University for a
removal of mefenamic acid was studied. Samples were
taken from the same locations as described previously.
The results of the samples taken from the hollow fiber
points (UF-HF) indicated that mefenamic acid was 74.0%
removed at this stage, whereas 94.3% of mefenamic acid
was removed after passing the spiral wound (SW) stage
(Tables 4 and 5). The sample taken after passing the point
of activated carbon column showed that mefenamic acid
was almost completely removed (98.8%). In addition,
samples taken after passing the RO unit demonstrated that
complete removal ofmefenamic acid was achieved (99.5%).
However, it should be realized that the initial concen-
trations of drug encountered by treatment elements at the
Table 4. Removal of mefenamic acid through a hollow fiber (UF-HF), spiral wound (UF-SW), activated carbon and reverse osmosis
from wastewater treatment plant at Al-Quds University.
Conc. of mefenamic Conc. of mefenamic Conc. of mefenamic
Acid (mg L) acid (mg L) acid (mg L)
No. Sample description First trial Second trial Third trial
1 Blank (before addition of Mefenamic acid) 0 0 0
2 The initial concentration of Mefenamic acid in
storage tank (after addition of Mefenamic acid)
42.00 40.0 39.5
3 HF-UF Feed point 18.80 37.90 38.3
Brine point 42.00 38.00 36.0
Product point 1.10 11.30 18.4
4 HF-SW Concentrated UF point 1.10 11.20 16.0
Permeated UF point 0.15 1.90 4.7
5 Activated carbon point 0.12 0.70 0.6
6 Reverse osmosis (RO) Brine RO point 0.45 0.72 0.6
Permeated RO point 0.07 0 0.5
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Table 5. The cumulative percentage removal of mefenamic acid
by the different purification elements in Table 4.
Trial Hollow Spiral Activated Reverse
No. fiber (HF) wound (SW) carbon osmosis (R.O)
1 97.8% 99.6% 99.7% 99.8%
2 71.8% 95.2% 98.2% 100.0%
3 53.4% 88.1% 98.5% 98.7%
Average 74.3% 94.3% 98.8% 99.5%
SD 18.2% 4.7% 0.8% 0.7%
Al-Quds WWTP diminish along their sequence. One de-
duction from Table 5 is that the combination of sequence
of purification elements enables to achieve almost complete
removal of mefenamic acid from its initial value of 40 mg
L−1. On the other hand the actual percentages of removal
relative to the initial solutions at some of the purification
elements are smaller. Thus the AC removes only an average
of 75.8% relative to the initial concentration of mefenamic
acid that reaches it, which is in general accord with Table 3.
The actual average percentage of removal of the drug by
the RO relative to the concentration of mefenamic acid that
reaches it is only 62%.
Conclusions
The kinetic study revealed that the NSAIDmefenamic acid
was stable in distilled water and in Al-Quds sludge for more
than 30 days. Hence, there is a pressing need to find an ap-
propriatemethod for the removal of this anti-inflammatory
drug from wastewater.
Adsorption isotherms and kinetics demonstrated that
the micelle (ODTMA)–clay complex has much higher effi-
ciency in the removal of mefenamic acid from water than
activated carbon. Filtration results showed the superior-
ity of micelle-clay complex over activated charcoal in the
removal of mefenamic acid from the environment. The
current combination of purification elements enables the
removal of mefenamic acid from wastewater almost com-
pletely, but the combined results suggest that incorpora-
tion of micelle-clay filters in wastewater treatment plants is
promising in removing mefenamic acid efficiently from the
environment.
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